[Effect of isradipine on urinary excretion of catecholamines and their metabolites in patients with pheochromocytoma].
An effect of calcium antagonist-isradipine-on catecholamines and their metabolites excretion with the urine in 4 patients with pheochromocytoma has been analysed. It was found that the excretion of OFFnoradrenaline and vanilaminomandelic acid is reduced. It may indicate inhibitory effect of calcium antagonists on catecholamines secretion in patients with pheochromocytoma.
Januszewicz
W
W
Kliniki Nadciśnienia Tetniczego i Chorób Naczyń AM, Warszawie.
Wocial
B
B
Chodakowska
J
J
Feltynowski
T
T
Lapiński
M
M
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy* / Q000652:urine; D000328:Adult; D002395:Catecholamines / Q000652:urine*; D005260:Female; D006801:Humans; D017275:Isradipine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000188:drug therapy* / Q000652:urine
D002395:Catecholamines; D017275:Isradipine
Wpływ isradypiny na wydalenie z moczem amin katecholowych i ich metabolitów u chorych z guzem chromochłonnym.